N6-Methyl-2'-beta-C-ethynyl adenosine

N6-Methyl-2’-beta-C-ethynyl adenosine is a synthetic purine nucleoside analog with demonstrated antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects, studied in vitro and in vivo, primarily involve the inhibition of DNA synthesis and the induction of apoptotic cell death in target cells.